Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells

被引:290
作者
Sanderson, JT [1 ]
Boerma, J [1 ]
Lansbergen, GWA [1 ]
van den Berg, M [1 ]
机构
[1] Univ Utrecht, IRAS, NL-3508 TD Utrecht, Netherlands
关键词
H295R; pesticides; fungicides; herbicides; organotin; aromatase; endocrine disruption; induction; inhibition; cAMP; atrazine; imidazole; triazole; triazine;
D O I
10.1006/taap.2002.9420
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Various pesticides known or suspected to interfere with steroid hormone function were screened in H295R cells for effects on catalytic activity and mRNA expression of aromatase. Dibutyl-, tributyl-, and triphenyltin chloride decreased aromatase and ethoxyresorufin O-deethylase activities concentration dependently (1-300 nM; 24-h exposure). However, these decreases occurred only at cytotoxic concentrations, indicated by decreases in mitochondrial MTT reduction and intracellular neutral red uptake. The organotins did not cause direct inhibition during the catalytic assay (1-1000 nM; 1.5-h exposure). The same was true for p,p'-DDT, and o,p-DDT, and o,p-DDE, which decreased aromatase activity only at cytotoxic concentrations ( greater than or equal to10 muM; 24-h exposure). p,p'-DDE had no effect on aromatase activity or cell viability at 1 and 10 muM. Various imidazole-like fungicides were aromatase inhibitors. Imazalil and prochloraz were potent mixed inhibitors (K-i/K-i' = 0.04/0.3 and 0.02/0.3 muM, respectively), whereas propiconazole, difenoconazole, and penconazole were less potent competitive inhibitors (K-i = 1.9, 4.5, and 4.7 muM, respectively). Fenarimol, tebuconazole, and hexaconazole decreased aromatase activity close to cytotoxic concentrations. Vinclozolin, as was shown previously for atrazine, induced aromatase activity and CYP19 mRNA levels about 2.5- and 1.5-fold, respectively. To investigate the mechanism of aromatase induction in H295R cells, the ability of the pesticides to increase intracellular cAMP levels was examined. Vinclozolin (100 muM) and atrazine (30 muM) increased cAMP levels about 1.5-fold above control. Forskolin and isobutyl methylxanthine (IBMX) increased cAMP levels 3 and 1.8-fold, respectively. Time-response curves for cAMP induction and concentration-response curves for aromatase induction by vinclozolin, atrazine, and IBMX were similar, suggesting that the mechanism of aromatase induction by these pesticides is mediated through inhibition of phosphodiesterase activity. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:44 / 54
页数:11
相关论文
共 53 条
[1]   Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients [J].
Agarwal, VR ;
Bulun, SE ;
Leitch, M ;
Rohrich, R ;
Simpson, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :3843-3849
[2]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[3]   STRUCTURE ACTIVITY RELATIONSHIPS OF THE INHIBITION OF HUMAN PLACENTAL AROMATASE BY IMIDAZOLE DRUGS INCLUDING KETOCONAZOLE [J].
AYUB, M ;
LEVELL, MJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 31 (01) :65-72
[4]  
Baatrup E, 2001, ENVIRON HEALTH PERSP, V109, P1063, DOI 10.2307/3454962
[5]   TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[6]   Aromatase inhibitors in breast cancer [J].
Brodie, A .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :61-65
[7]   EFFECT OF AN AROMATASE INHIBITOR, 4-HYDROXY-4-ANDROSTENE-3,17-DIONE, ON ESTROGEN-DEPENDENT PROCESSES IN REPRODUCTION AND BREAST-CANCER [J].
BRODIE, AMH ;
SCHWARZEL, WC ;
SHAIKH, AA ;
BRODIE, HJ .
ENDOCRINOLOGY, 1977, 100 (06) :1684-1695
[8]   REGULATION OF AROMATASE EXPRESSION IN HUMAN TISSUES [J].
BULUN, SE ;
SIMPSON, ER .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (01) :19-29
[9]  
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
[10]   Breast tumor aromatase: functional role and transcriptional regulation [J].
Chen, S ;
Zhou, D ;
Okubo, T ;
Kao, YC ;
Yang, C .
ENDOCRINE-RELATED CANCER, 1999, 6 (02) :149-156